ClassID:

95301

C07D417/12 - page 8 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#2101
20180044282
2018-02-15

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

#2102
20180037557
2018-02-08

Prodrugs of riluzole and their method of use

#2103
20180037556
2018-02-08

Compounds and methods for inducing browning of white adipose tissue

#2104
20180037554
2018-02-08

Aminoquinazoline compounds as Aantagonist

#2105
20180036290
2018-02-08

Riluzole prodrugs and their use

#2106
20180030075
2018-02-01

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#2107
20180030043
2018-02-01

Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate

#2108
20180030036
2018-02-01

Factor IXa inhibitors

#2109
20180030034
2018-02-01

Quinazolines as potassium ion channel inhibitors

#2110
20180030006
2018-02-01

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

#2111
20180029984
2018-02-01

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#2112
20180022767
2018-01-25

Compounds for treatment of complement mediated disorders

#2113
20180022766
2018-01-25

Ether compounds for treatment of complement mediated disorders

#2114
20180022759
2018-01-25

Compounds, compositions and methods

#2115
20180022742
2018-01-25

Autotaxin inhibitors

#2116
20180022741
2018-01-25

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#2117
20180022738
2018-01-25

3-substituted cyclopentylamine derivatives

#2118
20180022723
2018-01-25

Compounds for the treatment of hepatitis C

#2119
20180022716
2018-01-25

Polymerizable compound and optical isomer

#2120
20180022707
2018-01-25

Therapeutic compounds and uses thereof

#2121
20180022706
2018-01-25

Cannabinoid receptor mediating compounds

#2122
20180022705
2018-01-25

Cannabinoid receptor mediating iminopyrazole compounds

#2123
20180021346
2018-01-25

GLP-1 receptor modulators

#2124
20180016269
2018-01-18

Compounds having estrogen receptor alpha degradation activity and uses thereof

#2125
20180016247
2018-01-18

CYCLIC PROTEIN TYROSINE KINASE INHIBITORS

#2126
20180016245
2018-01-18

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#2127
20180016234
2018-01-18

Herbicidal phenylpyridines

#2128
20180015097
2018-01-18

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#2129
20180013069
2018-01-11

Conjugated polymers based on terthiophene and their applications

#2130
20180009845
2018-01-11

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

#2131
20180009792
2018-01-11

Chromenone inhibitors of monocarboxylate transporters

#2132
20180009784
2018-01-11

Quinazoline and quinoline compounds and uses thereof

#2133
20180009754
2018-01-11

Anthelmintic compounds, compositions and method of using thereof

#2134
20180008554
2018-01-11

Immunomodulator compounds

#2135
20180003702
2018-01-04

T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds

#2136
20180002358
2018-01-04

Tricyclic sulfones as RORγ modulators

#2137
20180002308
2018-01-04

Tricyclic spiro compound

#2138
20180002293
2018-01-04

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#2139
20180002288
2018-01-04

USE OF PICOLINAMIDES AS FUNGICIDES

#2140
20180000832
2018-01-04

N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulators

#2141
20180000806
2018-01-04

Hydrazone derivatives for the treatment of cancer

#2142
20180000772
2018-01-04

Zinc complexes of hydrazones and (thio)semicarbazones and their use for the treatment of cancer

#2143
20180000080
2018-01-04

Picolinamides as fungicides

#2144
20170369783
2017-12-28

Polymerizable compound and optically anisotropic object

#2145
20170369484
2017-12-28

Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use

#2146
20170369483
2017-12-28

Aryl sulfonamides

#2147
20170369482
2017-12-28

Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis

#2148
20170369480
2017-12-28

Compounds, compositions, and methods for increasing CFTR activity

#2149
20170369462
2017-12-28

Modulation of Bacterial Quorum Sensing with Synthetic Ligands

#2150
20170369446
2017-12-28

MONOCYCLIC HETEROARYL COMPOUNDS

#2151
20170369444
2017-12-28

INHIBITORS OF HISTONE DEMETHYLASES

#2152
20170368188
2017-12-28

Treatment or prophylaxis of proliferative conditions

#2153
20170362508
2017-12-21

POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY

#2154
20170362259
2017-12-21

Process and intermediates for making tubulysin analogs

#2155
20170362215
2017-12-21

1-methylpyrazole-piperazine compounds having multimodal activity against pain

#2156
20170362214
2017-12-21

Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis

#2157
20170362184
2017-12-21

PRO-SURVIVAL COMPOUNDS

#2158
20170360045
2017-12-21

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#2159
20170360041
2017-12-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests

#2160
20170355678
2017-12-14

C-met modulators and methods of use

#2161
20170355671
2017-12-14

Peripherally substituted monocyclic beta-lactams

#2162
20170349601
2017-12-07

Process for the preparation of lurasidone and its intermediate

#2163
20170349557
2017-12-07

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

#2164
20170349537
2017-12-07

Inhibitors of lysine gingipain

#2165
20170348318
2017-12-07

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

#2166
20170348297
2017-12-07

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

#2167
20170342088
2017-11-30

ULK1 inhibitors and methods using same

#2168
20170342074
2017-11-30

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#2169
20170334948
2017-11-23

LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV

#2170
20170334903
2017-11-23

Method of preparing glucosylceramide synthase inhibitors

#2171
20170334902
2017-11-23

Benzenesulfonamide compounds and their use as therapeutic agents

#2172
20170334899
2017-11-23

AMINO-SUBSTITUTED ISOTHIAZOLES

#2173
20170334870
2017-11-23

Prodrugs of riluzole and their method of use

#2174
20170334869
2017-11-23

Mitochondrial uncouplers for treatment of metabolic diseases and cancer

#2175
20170327503
2017-11-16

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#2176
20170327495
2017-11-16

Pesticidally active amide heterocyclic derivatives with sulphur containing substituents

#2177
20170327493
2017-11-16

CXCR7 receptor modulators

#2178
20170327469
2017-11-16

Compounds and methods for the targeted degradation of androgen receptor

#2179
20170320888
2017-11-09

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

#2180
20170320869
2017-11-09

Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes

#2181
20170320868
2017-11-09

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

#2182
20170320839
2017-11-09

Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis

#2183
20170320835
2017-11-09

HIV replication inhibiting pyrimidines

#2184
20170320828
2017-11-09

Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

#2185
20170319602
2017-11-09

Compositions and methods for treating ocular diseases

#2186
20170319565
2017-11-09

METHODS AND DRUG PRODUCTS FOR TREATING ALZHEIMER'S DISEASE

#2187
20170319564
2017-11-09

2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

#2188
20170319559
2017-11-09

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#2189
20170313717
2017-11-02

GLP-1 receptor modulators

#2190
20170313712
2017-11-02

Diheteroaryl histone deacetylase inhibitors and their use in therapy

#2191
20170313690
2017-11-02

Modulators of calcium release-activated calcium channel

#2192
20170313659
2017-11-02

Compounds and methods for the treatment of cystic fibrosis

#2193
20170313658
2017-11-02

2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease

#2194
20170311596
2017-11-02

Herbicidal compounds

#2195
20170306233
2017-10-26

Polymerizable compound and optically anisotropic body

#2196
20170305895
2017-10-26

Substituted aminothiazoles for the treatment of tuberculosis

#2197
20170305864
2017-10-26

Heterocyclic compounds as pesticides

#2198
20170305857
2017-10-26

N-ACYLPIPERIDINE ETHER TROPOMYOSIN-RELATED KINASE INHIBITORS

#2199
20170305824
2017-10-26

SMALL MOLECULE INHIBITORS OF NECROPTOSIS

#2200
20170298085
2017-10-19

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#2201
20170298084
2017-10-19

Amide compounds for treatment of complement mediated disorders

#2202
20170298082
2017-10-19

Glycosidase inhibitors

#2203
20170298075
2017-10-19

Tetrahydroisoquinoline derived PRMT5-inhibitors

#2204
20170298058
2017-10-19

HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE

#2205
20170298057
2017-10-19

Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams

#2206
20170298056
2017-10-19

SMALL MOLECULE INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF

#2207
20170298054
2017-10-19

Compositions and methods for inhibition of the JAK pathway

#2208
20170296550
2017-10-19

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

#2209
20170291897
2017-10-12

Therapeutic compounds as inhibitors of the orexin-1 receptor

#2210
20170291888
2017-10-12

1,2,4-triazine-4-amine derivatives

#2211
20170290830
2017-10-12

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#2212
20170290824
2017-10-12

2-aminothiazole derivative or salt thereof

#2213
20170290815
2017-10-12

Glutaminase inhibitors

#2214
20170290795
2017-10-12

URAT1 inhibitor

#2215
20170283429
2017-10-05

Compounds for the treatment of paramyxovirus viral infections

#2216
20170280721
2017-10-05

1,2,3-thiadiazol-5yl-urea derivatives, use thereof for regulating plant senescence and preparations containing these derivatives

#2217
20170275301
2017-09-28

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#2218
20170275291
2017-09-28

Indazole compounds as FGFR kinase inhibitor, preparation and use thereof

#2219
20170275275
2017-09-28

BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS

#2220
20170275274
2017-09-28

Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

#2221
20170275261
2017-09-28

1,3,4-THIADIAZOLES HAVING A HERBICIDAL ACTIVITY, THEIR AGRONOMICAL COMPOSITIONS AND RELATIVE USE

#2222
20170273966
2017-09-28

Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

#2223
20170273943
2017-09-28

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#2224
20170267673
2017-09-21

CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE

#2225
20170267648
2017-09-21

SUBSTITUTED URACILS AS CHYMASE INHIBITORS

#2226
20170267643
2017-09-21

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#2227
20170267638
2017-09-21

Compounds, compositions and methods

#2228
20170266160
2017-09-21

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

#2229
20170260207
2017-09-14

Biaryl amide compounds as kinase inhibitors

#2230
20170260206
2017-09-14

Androgen receptor modulating compounds

#2231
20170260181
2017-09-14

S-imino-S-oxo iminothiazine compounds as bace inhibitors, compositions, and their use

#2232
20170253591
2017-09-07

Heterocyclic compound

#2233
20170253586
2017-09-07

Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II

#2234
20170253569
2017-09-07

Thiazolidinone compounds and use thereof

#2235
20170252349
2017-09-07

Aryl-or heteroaryl-substituted benzene compounds

#2236
20170252317
2017-09-07

N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

#2237
20170247388
2017-08-31

Inhibitors of IRAK4 activity

#2238
20170247366
2017-08-31

SUBSTITUTED 4-ALKOXYPICOLINAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME

#2239
20170247365
2017-08-31

Compounds

#2240
20170247326
2017-08-31

Substituted Pyrrolidine Carboxamide Compounds

#2241
20170246300
2017-08-31

C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

#2242
20170246167
2017-08-31

2,4-pyrimidinediamine compounds and their uses

#2243
20170246165
2017-08-31

Process for the preparation of Lurasidone hydrochloride

#2244
20170240540
2017-08-24

3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1)-one derivatives as fungicides

#2245
20170233411
2017-08-17

Thiazolyl-containing compounds for treating proliferative diseases

#2246
20170233383
2017-08-17

Crystalline forms of a BACE inhibitor, compositions, and their use

#2247
20170233382
2017-08-17

PROCESSES FOR THE PREPARATION OF A BACE INHIBITOR

#2248
20170233381
2017-08-17

Dual mechanism inhibitors for the treatment of disease

#2249
20170233380
2017-08-17

Compounds as ROR gamma modulators

#2250
20170233379
2017-08-17

Compounds, compositions, and methods for increasing CFTR activity

#2251
20170233377
2017-08-17

Heterocyclic compounds as NaV channel inhibitors and uses thereof

#2252
20170233352
2017-08-17

HSP70 modulators and methods for making and using the same

#2253
20170233345
2017-08-17

SUBSTITUTED QUINOLINE-4-CARBOXAMIDES AND USE THEREOF

#2254
20170233340
2017-08-17

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

#2255
20170231999
2017-08-17

IDO inhibitors

#2256
20170226127
2017-08-10

Compounds, compositions and methods

#2257
20170226124
2017-08-10

PHTHALAZINONE DERIVATIVES

#2258
20170226106
2017-08-10

CXCR4 receptor antagonists

#2259
20170226099
2017-08-10

Quinazoline derivative

#2260
20170226098
2017-08-10

Crystalline forms of a BACE inhibitor, compositions, and their use

#2261
20170226089
2017-08-10

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

#2262
20170217961
2017-08-03

Pyrimidine-2,4-diamine derivatives for treatment of cancer

#2263
20170217950
2017-08-03

Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same

#2264
20170217949
2017-08-03

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

#2265
20170217913
2017-08-03

Class of mu-opioid receptor agonists

#2266
20170217905
2017-08-03

Aminopyrimidine derivatives for use as modulators of kinase activity

#2267
20170217885
2017-08-03

SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#2268
20170204090
2017-07-20

Deoxycytidine kinase inhibitors

#2269
20170197976
2017-07-13

MTH1 inhibitors for treatment of cancer

#2270
20170197973
2017-07-13

Immunoregulatory agents

#2271
20170197971
2017-07-13

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#2272
20170197923
2017-07-13

Bifunctional compounds and use for reducing uric acid levels

#2273
20170197915
2017-07-13

Estrogen receptor modulators and uses thereof

#2274
20170196862
2017-07-13

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#2275
20170190709
2017-07-06

Compositions useful in treating brain-related diseases or disorders and methods using same

#2276
20170190671
2017-07-06

BIS(ARYL)CATECHOL DERIVATIVES AS HERBICIDES

#2277
20170190669
2017-07-06

Pyrazole compounds and methods of making and using same

#2278
20170189410
2017-07-06

Amino compounds for treatment of complement mediated disorders

#2279
20170189390
2017-07-06

Tetrahydroisoquinolin-1-one derivative or salt thereof

#2280
20170183337
2017-06-29

TRPV1 antagonists including dihydroxy substituent and uses thereof

#2281
20170183336
2017-06-29

Sweet flavor modifier

#2282
20170183335
2017-06-29

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#2283
20170183334
2017-06-29

Dasatinib salts

#2284
20170183332
2017-06-29

Heterocyclic amides as kinase inhibitors

#2285
20170183331
2017-06-29

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#2286
20170183311
2017-06-29

Therapeutic compounds and compositions

#2287
20170183308
2017-06-29

LSD1 inhibitors

#2288
20170174704
2017-06-22

Quinoxaline compounds and uses thereof

#2289
20170174703
2017-06-22

Quinoline derivatives as SMO inhibitors

#2290
20170174691
2017-06-22

Protein kinase conjugates and inhibitors

#2291
20170174674
2017-06-22

Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels

#2292
20170174673
2017-06-22

Pyridazine compounds as JAK inhibitors

#2293
20170174641
2017-06-22

Anti-amyloid compounds containing benzofurazan

#2294
20170173176
2017-06-22

Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule

#2295
20170173168
2017-06-22

Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule

#2296
20170166577
2017-06-15

Apelin receptor (APJ) agonists and uses thereof

#2297
20170166548
2017-06-15

Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

#2298
20170166533
2017-06-15

Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

#2299
20170166524
2017-06-15

N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

#2300
20170158704
2017-06-08

Pyrimidinone derivative having autotaxin-inhibitory activity

#2301
20170158698
2017-06-08

TrKA kinase inhibitors, compositions and methods thereof

#2302
20170158692
2017-06-08

Compounds and methods for inhibiting fascin

#2303
20170158686
2017-06-08

Substituted pyrimidines for inhibiting Raf kinase activity

#2304
20170158685
2017-06-08

Histone demethylase inhibitors

#2305
20170158684
2017-06-08

Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient

#2306
20170158680
2017-06-08

Heterocyclic compounds, process for preparation of the same and use thereof

#2307
20170158673
2017-06-08

Quinazolinone derivatives as PARP inhibitors

#2308
20170152270
2017-06-01

Method for producing pyridine compound

#2309
20170152262
2017-06-01

Vinylogous thioester compounds and methods of use

#2310
20170152250
2017-06-01

Insecticidal compounds based on isoxazoline derivatives

#2311
20170152233
2017-06-01

Amino quinazolines as kinase inhibitors

#2312
20170152232
2017-06-01

NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND

#2313
20170152230
2017-06-01

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#2314
20170146519
2017-05-25

STING AGONISTS AND METHODS OF SELECTING STING AGONISTS

#2315
20170145038
2017-05-25

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#2316
20170145003
2017-05-25

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#2317
20170144980
2017-05-25

Use of substituted oxadiazoles for combating phytopathogenic fungi

#2318
20170144978
2017-05-25

Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections

#2319
20170144971
2017-05-25

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#2320
20170143845
2017-05-25

Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule

#2321
20170143672
2017-05-25

Tetrazole-substituted arylamides as PXand PXantagonists

#2322
20170137416
2017-05-18

6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives

#2323
20170137415
2017-05-18

SULFONAMIDE COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORS

#2324
20170137401
2017-05-18

Chemokine CXCR4 and CCR5 receptor modulators and uses related thereto

#2325
20170137393
2017-05-18

Aryl sultam derivatives as RORc modulators

#2326
20170137392
2017-05-18

Ribonucleotide reductase inhibitors and methods of use

#2327
20170135992
2017-05-18

Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway

#2328
20170129881
2017-05-11

TRPM8 antagonists

#2329
20170129861
2017-05-11

6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides

#2330
20170121346
2017-05-04

Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2

#2331
20170121345
2017-05-04

Anti-fibrotic pyridinones

#2332
20170121292
2017-05-04

HIV REPLICATION INHIBITING PYRIMIDINES

#2333
20170121291
2017-05-04

COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY

#2334
20170120231
2017-05-04

Complexes

#2335
20170119780
2017-05-04

Aryl- or heteroaryl-substituted benzene compounds

#2336
20170114071
2017-04-27

TrkA kinase inhibitors, compositions and methods thereof

#2337
20170114061
2017-04-27

PRMT5 inhibitors and uses thereof

#2338
20170114060
2017-04-27

NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME

#2339
20170114055
2017-04-27

Histone demethylase inhibitors

#2340
20170112805
2017-04-27

Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders

#2341
20170107226
2017-04-20

Dihydroxy aromatic heterocyclic compound

#2342
20170107202
2017-04-20

Compounds useful as immunomodulators

#2343
20170107178
2017-04-20

Indole derivatives for use in medicine

#2344
20170101410
2017-04-13

Substituted prolines/piperidines as orexin receptor antagonists

#2345
20170101403
2017-04-13

Isothiazole derivatives as CFTR modulators

#2346
20170096421
2017-04-06

Carboxamide derivatives and use thereof

#2347
20170096416
2017-04-06

Pyrazole-substituted arylamides as P2Xand P2Xantagonists

#2348
20170096404
2017-04-06

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#2349
20170095458
2017-04-06

Heteroaryl sulfonamides and CCR2/CCR9

#2350
20170088527
2017-03-30

Fused heterocyclic compounds as ion channel modulators

#2351
20170081311
2017-03-23

Insecticidally active amide derivatives with sulfur-substituted phenyl or pyridine groups

#2352
20170081290
2017-03-23

2,4-pyrimidinediamine compounds and their uses

#2353
20170073340
2017-03-16

Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists

#2354
20170073337
2017-03-16

DIHYDROTHIAZINE AND DIHYDROOXAZINE DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY

#2355
20170073325
2017-03-16

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#2356
20170073314
2017-03-16

Human plasma kallikrein inhibitors

#2357
20170073313
2017-03-16

Benzomorphan analogs and use thereof

#2358
20170066758
2017-03-09

Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication

#2359
20170066757
2017-03-09

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#2360
20170066756
2017-03-09

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#2361
20170066755
2017-03-09

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#2362
20170066741
2017-03-09

2-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's Disease

#2363
20170066733
2017-03-09

Mitotic kinesin inhibitors and methods of use thereof

#2364
20170066731
2017-03-09

Small molecule fatty acid synthase inhibitors

#2365
20170066718
2017-03-09

Urea derivative or pharmacologically acceptable salt thereof

#2366
20170065565
2017-03-09

Isoxazoline-substituted benzamide compound and pesticide

#2367
20170064962
2017-03-09

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#2368
20170064961
2017-03-09

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#2369
20170057978
2017-03-02

Anti-viral compounds, pharmaceutical compositions, and methods of use thereof

#2370
20170057938
2017-03-02

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#2371
20170057930
2017-03-02

Compounds for treatment of cancer

#2372
20170056382
2017-03-02

Compounds and methods for kinase modulation, and indications therefor

#2373
20170050942
2017-02-23

3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS

#2374
20170050931
2017-02-23

Inhibitors of RPN11

#2375
20170050926
2017-02-23

Benzamide compounds and related methods of use

#2376
20170050925
2017-02-23

Sulfur derivatives as chemokine receptor modulators

#2377
20170049762
2017-02-23

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#2378
20170044151
2017-02-16

2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

#2379
20170037056
2017-02-09

Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use

#2380
20170037044
2017-02-09

Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof

#2381
20170037042
2017-02-09

SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS

#2382
20170037036
2017-02-09

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I

#2383
20170037016
2017-02-09

GUANIDINE COMPOUNDS AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS

#2384
20170037010
2017-02-09

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

#2385
20170029442
2017-02-02

Heterocyclic compounds and uses thereof

#2386
20170029417
2017-02-02

Cyclopropanamine compound and use thereof

#2387
20170029416
2017-02-02

Sweet flavor modifier

#2388
20170029381
2017-02-02

Tetrahydro-benzoimidazolyl modulators of TGR5

#2389
20170027173
2017-02-02

INSECTICIDAL COMPOUNDS

#2390
20170022192
2017-01-26

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

#2391
20170022191
2017-01-26

Benzamides

#2392
20170022166
2017-01-26

HDMX inhibitors and their use for cancer treatment

#2393
20170015659
2017-01-19

Prodrugs of NH-acidic compounds

#2394
20170015658
2017-01-19

Hepatitis B core protein allosteric modulators

#2395
20170015657
2017-01-19

Compound having selective EP2 agonist activity

#2396
20170015645
2017-01-19

SUBSTITUTED PYRAN DERIVATIVES

#2397
20170015637
2017-01-19

Heteroaryl butanoic acid derivatives

#2398
20170015631
2017-01-19

PKM2 modulators and methods for their use

#2399
20170015627
2017-01-19

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#2400
20170014408
2017-01-19

Hepatitis B antiviral agents